Press Release: Canadian psychedelic PharmAla Biotech to supply MDMA to Yale

Canadian psychedelic stock PharmAla Biotech (CSE:MDMA) is up after signing a contract to supply MDMA for a clinical trial at Yale University The company is actively expanding its roster of research partners PharmAla focuses on the research, development and manufacturing of MDXX-class molecules, including MDMA, for clinical trials and commercial sales PharmAla Biotech stock is […]